Who invested in Protego Biopharma?
Protego Biopharma's investors include Novartis Venture Fund, Forbion Capital Partners, Lightspeed Venture Partners, MPM Capital and Omega Funds, and 5 more on record. Novartis Venture Fund led its latest round.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$130Mraised across 1 round since 2025, from 3 sources
Reported by Firms' own news pages and 2 othersSEC filing: $33M sold, first sale Oct 2025
Protego Biopharma's investors include Novartis Venture Fund, Forbion Capital Partners, Lightspeed Venture Partners, MPM Capital and Omega Funds, and 5 more on record. Novartis Venture Fund led its latest round.
Protego Biopharma has raised $130M across 1 round since 2025.
Protego Biopharma's most recent round was a Series B of $130M in Dec 2025, led by Novartis Venture Fund.
Its most recent round, $130M in Dec 2025, is also its largest on record.
Protego Biopharma's first round on record, in Dec 2025, was backed by Novartis Venture Fund, Forbion Capital Partners and Lightspeed Venture Partners and 7 others.
Protego Biopharma's latest named round is a Series B, in Dec 2025.
Protego Biopharma is based in the United States.
Novartis Venture Fund led the Series B in 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.